Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Antiaging Quantum Living Inc AAQL

Antiaging Quantum Living Inc. is an investment holding company. It focuses on Website development, maintenance and online business advertisement. Its primary business operations are conducted through its subsidiaries AAQL Inc., AAQL HK Limited, Antiaging Doctor Hangzhou Holding LTD (Dao Ling Doctor Hangzhou), Dao Ling Doctor (Zhejiang) Health Management Limited (Dao Ling Doctor Zhejiang), and... see more

Recent & Breaking News (OTCPK:AAQL)

Achillion to Present at Two Upcoming Investor Conferences

Troy Schwensen March 1, 2013

Achillion Pharmaceuticals Announces Closing of Public Offering

Troy Schwensen February 27, 2013

Technical Analysis on VIVUS and Achillion Pharma: Highlights on These Biotech Companies

PR Newswire February 26, 2013

Achillion Pharmaceuticals Announces Pricing of Public Offering of Common Stock

Troy Schwensen February 21, 2013

Achillion to Report Fourth Quarter and Year End 2012 Financial Results and Host Conference Call on February 20, 2013

Troy Schwensen February 19, 2013

Achillion to Present at the 2013 Leerink Swann Global Healthcare Conference

Troy Schwensen February 8, 2013

U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous

Marketwired February 4, 2013

Achillion to Present at the Noble Financial Capital Markets' Ninth Annual Equity Conference

Troy Schwensen January 17, 2013

Record Levels of Available Cash and Moderate R&D Development Will See Big Pharma M&A Activity Increase in 2013

Marketwired January 9, 2013

Free Research Reports on ACHN, CHTP, NSM and SQNM Issued by the Bedford Report

Marketwired January 8, 2013

Achillion Reports Interim Results on ACH-3102

Troy Schwensen January 7, 2013

Stockhouse @ the Bell: Stocks get housing boost as oil declines

Stockhouse Editorial September 19, 2012